• LAST PRICE
    34.6900
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    28.0700/ 1
  • Ask / Lots
    36.0000/ 1
  • Open / Previous Close
    --- / 34.6900
  • Day Range
    ---
  • 52 Week Range
    Low 29.7200
    High 76.9800
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 34.31
TimeVolumeIMCR
09:32 ET232534.1
09:35 ET14034.15
09:37 ET25034.325
09:42 ET20034.655
09:44 ET135034.595
09:46 ET10034.46
09:53 ET31034.37
09:57 ET265534.34
10:00 ET30534.04
10:02 ET25234
10:04 ET99734.015
10:11 ET110034.015
10:18 ET20034.21
10:27 ET40034.16
10:29 ET10034.205
10:31 ET20034.2
10:33 ET45934.2
10:38 ET10034.5
10:42 ET40034.44
10:44 ET10034.42
10:45 ET20534.49
10:49 ET20034.57
10:54 ET36634.59
10:56 ET84034.41
11:05 ET25034.41
11:07 ET10034.39
11:09 ET87234.165
11:12 ET30034.2
11:21 ET50034.22
11:23 ET10034.25
11:34 ET30034.215
11:36 ET30034.29
11:38 ET41334.44
11:39 ET70034.5775
11:41 ET166634.44
11:43 ET20034.27
11:45 ET110434.21
11:59 ET57234.22
12:01 ET40034.13
12:03 ET62034.27
12:06 ET20034.285
12:08 ET43334.17
12:14 ET128433.88
12:19 ET50033.935
12:21 ET71034.015
12:26 ET10034.01
12:28 ET100034.12
12:30 ET20034.085
12:35 ET10034.13
12:37 ET254134.15
12:42 ET499034.2
12:46 ET301834.39
12:48 ET60034.275
12:51 ET10034.27
12:53 ET307734.28
12:55 ET10034.22
12:57 ET10034.22
01:00 ET40034.34
01:02 ET120034.275
01:08 ET191734.17
01:11 ET244034.16
01:15 ET30034.13
01:22 ET10034.135
01:24 ET12834.135
01:26 ET95133.97
01:27 ET20033.96
01:29 ET347334.06
01:31 ET60034.12
01:36 ET20034.215
01:40 ET61234.285
01:42 ET10034.265
01:44 ET227534.36
01:45 ET10034.41
01:47 ET43034.51
01:49 ET308334.49
01:54 ET20034.505
01:58 ET80934.61
02:00 ET50034.53
02:02 ET45034.528479
02:03 ET20034.51
02:05 ET10034.455
02:07 ET100034.54
02:09 ET20034.52
02:12 ET20034.52
02:16 ET30034.46
02:18 ET255734.3
02:20 ET30034.4
02:21 ET159534.39
02:25 ET57634.46
02:27 ET10034.485
02:30 ET101034.59
02:32 ET10034.65
02:34 ET40034.575
02:45 ET40034.575
02:48 ET22534.575
02:50 ET31134.575
02:52 ET20034.57
02:54 ET30034.58
02:56 ET10034.59
02:57 ET269634.58
02:59 ET10034.43
03:03 ET60034.36
03:06 ET30034.345
03:08 ET30534.37
03:10 ET41234.35
03:12 ET10034.34
03:14 ET10034.38
03:19 ET40034.38
03:21 ET30034.36
03:24 ET60034.2625
03:26 ET104234.24
03:28 ET10034.24
03:32 ET90034.29
03:33 ET10034.335
03:35 ET10034.33
03:37 ET20034.33
03:39 ET30034.33
03:42 ET60034.29
03:44 ET30034.29
03:46 ET223934.35
03:48 ET50034.295
03:50 ET50034.295
03:51 ET60034.36
03:53 ET164834.48
03:55 ET175034.48
03:57 ET101334.5
04:00 ET4208034.69
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIMCR
Immunocore Holdings PLC
1.7B
-32.4x
---
United StatesHROW
Harrow Inc
1.9B
-55.2x
---
United StatesINVA
Innoviva Inc
1.3B
29.3x
-8.76%
United StatesOCUL
Ocular Therapeutix Inc
1.7B
-10.2x
---
United StatesEOLS
Evolus Inc
866.2M
-15.0x
---
United StatesLGND
Ligand Pharmaceuticals Inc
2.2B
54.5x
-12.71%
As of 2024-11-11

Company Information

Immunocore Holdings plc is a United Kingdom-based commercial-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies, ImmTAX, which immunes mobilizing monoclonal TCRs Against X disease, designed to treat a range of diseases, including cancer, autoimmune and infectious disease. The Company has a clinical-stage pipeline of wholly owned and partnered programs across three different therapeutic areas: oncology, infectious diseases, and autoimmune and inflammation diseases. Its lead product, KIMMTRAK, is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma (mUM), in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. Its clinical programs are being conducted with patients with a range of cancers including melanoma, lung, gastric and others.

Contact Information

Headquarters
90 Park Drive, Milton Park, AbingdonABINGDON, United Kingdom OX14 4RY
Phone
123-543-8600
Fax
---

Executives

Independent Chairman of the Board
John Bell
Chief Executive Officer, Director
Bahija Jallal
Chief Financial Officer, Head of Strategy
Brian Di Donato
Chief Human Resource Officer
Tina St Leger
Head of Research and Development
David Berman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.7B
Revenue (TTM)
$281.5M
Shares Outstanding
50.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.76
EPS
$-1.07
Book Value
$7.42
P/E Ratio
-32.4x
Price/Sales (TTM)
6.2
Price/Cash Flow (TTM)
---
Operating Margin
-21.78%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.